Top MN Democrat Shot and Killed in a Targeted Attack
About That White Guy Laughing in the Face of a Black Mom Trying...
I Was Told by the Liberal Media That These Actions Constituted an Insurrection
Why Iran's Anti-Mossad Unit Never Saw These Israeli Attacks Coming
Justice Department Is Suing This State for Shielding Illegal Immigrants From Deportation
DHS Chimes in After Kardashian Calls Out ICE Enforcement Operations
Nearly Half of Americans Back Israel’s Airstrikes on Iran Despite Democrat Opposition
Look Who the Suspect in Minnesota Murder of Dem Lawmaker Is Connected To
China Sounds Alarm Over Israel Strikes on Iran, Doubling Down on Support for...
Suspect Who KiIIed Minnesota Dem Had 'NO KINGS' Fliers In His Car
Child Transitioning Is Not Progress. It's a Tragedy.
Trump Releases Statement After MN Dem Killed In 'Targeted Political Assassination'
Nicolle Wallace’s Take on the Alex Padilla Situation Is Something Else
Tim Walz Prays for Rain on Trump’s Army Parade
Israel’s National Security Adviser: Only Trump Can Secure Deal to End Iran’s Nuclear...
Tipsheet

FDA to Lift Longstanding Regulations on Abortion Pill Distribution

AP Photo/Jeff Roberson

The Food and Drug Administration (FDA) announced on Monday that federal regulations on the abortion pill, also known as Mifepristone, will no longer be enforced. The Center for Drug Evaluation and Research (CDER) evaluated the risks and public health consequences of the drug, and the FDA determined that the risks are minimal enough to distribute to women without a medical consultation. 

Advertisement

The abortion industry lobbied for the Risk Evaluation and Mitigation Strategy (REMS) mandate for an in-person medical appointment to be lifted, and the FDA is relaxing on account of the pandemic; the drug will now be able to be distributed via mail and telemedicine.

“CDER found that the small number of adverse events reported to FDA during the COVID-19 public health emergency (PHE) provide no indication that any program deviation or noncompliance with the Mifepristone REMS Program contributed to the reported adverse events,” the acting FDA commissioner wrote to the American College of Obstetricians and Gynecologists (ACOG). “In summary, provided the other requirements of the Mifepristone REMS Program are met, and given that the in-person dispensing of mifepristone for medical termination of early pregnancy may present additional COVID-related risks to patients and healthcare personnel because it may involve a clinic visit solely for this purpose, CDER intends to exercise enforcement discretion during the COVID-19 PHE with respect to the in-person dispensing requirement of the Mifepristone REMS Program, including any in-person requirements that may be related to the Patient Agreement Form…”

Advertisement

The FDA’s “out of line” decision drew criticism from Live Action, a prominent pro-life group. 

“The abortion pill was created to kill children, has caused a catastrophic death toll, and poses a serious threat to maternal health. Since the FDA first approved this drug, nearly 4 million preborn children have been killed. The FDA itself reports that at least 24 women have died from taking the pill. The FDA has also received over 4,000 reports of adverse events from women experiencing hospitalization, hemorrhage, excruciating abdominal pain, and severe life threatening infections after taking the abortion pill regimen,” the group’s president, Lila Rose, released in a statement. “The FDA is out of line and the American people should respond en masse calling for them to pull the pill.”

Planned Parenthood, the nation's largest abortion provider, praised the FDA's move.

Advertisement

The FDA’s decision allows for medical consultations for the abortion pill to be sidestepped.

Join the conversation as a VIP Member

Recommended

Trending on Townhall Videos

Advertisement
Advertisement
Advertisement